[시장보고서]숙주 세포 단백질 검사 시장 예측(-2032년)

숙주 세포 단백질 검사 시장 예측(-2032년)

Host Cell Protein Testing Market Research Report Forecast till 2032

상품코드 : 1452461 해당 상품은 즉시 배송 가능합니다

리서치사 : Market Research Future

발행일 : 2024년 03월

페이지 정보 : 영문 127 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,950

￦ 7,089,000

PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다.

US $ 5,950

￦ 8,521,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 기업 내 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다.

US $ 7,250

￦ 10,383,000

PDF & Excel (Enterprise License)

PDF, Excel 보고서를 동일 기업이 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능하며, 인쇄 가능합니다.

한글목차

샘플 요청 목록에 추가

숙주 세포 단백질 검사 시장 규모는 예측 기간 동안 5.73%의 연평균 복합 성장률(CAGR)로 견조한 성장을 나타낼 것으로 예측되고 있습니다. R&D의 진전 및 바이오의약품 사업의 진보가 사업 부문의 발전을 촉진하고 있습니다.

숙주 세포 단백질 검사 시장은 생물학적 제제 및 바이오시밀러에 대한 관심의 확대, 감염의 일반화, 기술 혁신의 수용 등의 요인에 의해 예측 기간 동안 큰 성장을 나타낼 것으로 예측되고 있습니다. 시장의 중심 기업은 새로운 체제를 육성하기 위해 R&D에 자원을 투입하고 있습니다.

이 보고서는 세계의 숙주 세포 단백질 검사 시장을 조사했으며,, 시장 정의 및 개요, 시장 성장에 대한 영향요인 및 시장 기회의 분석, 시장 규모 추이 및 예측, 각종 구분, 지역별 분석, 경쟁 환경, 주요 기업 프로파일 등을 정리했습니다.

영문목차

Market Overview

Host Cell Protein Testing Market is estimated to register a healthy CAGR of 5.73% during the review period. The developing Research and development exercises and advancements in the biopharmaceutical business are driving business sector development.

The host Cell Protein testing market is supposed to observe hearty development during the conjecture time frame, driven by elements, for example, expanding interest for biologics and biosimilars, developing commonness of ongoing infections, and reception of trend setting innovations for HCP testing. Also, central parts in the market are putting resources into Research and development exercises to foster new arrangements, as most would consider to be normal to additional fuel the market development.

The rise of constant and viral illnesses all over the planet has expanded use on Research and development drives. The medication improvement process is being advanced quickly by mechanical progression and development in biomedical sciences. This headway has sped up the advancement of medications and diminished the medication lifecycle period by 500 days. Also, instructive establishments and exploration associations are putting resources into the development of melded and useful proteins. The rising interests in drug solidness have expanded the interest for better host cell protein strategies. In addition, Researchers are exploring techniques to keep antibodies and proteins stable in natural conditions.

Moreover, the developing interest for protein-based antibodies to treat viral, bacterial, and other microorganism-based illnesses has energized worldwide exploration endeavors. The rising commonness of sicknesses, for example, paroxysmal nighttime hemoglobinuria and element VII and VIII inadequacy has helped examination into improved restorative and business protein producing. In this manner, during the gauge time frame, such open doors are projected to drive the host cell protein testing market.

Market Segmentation

Based on type, the Host Cell Protein Testing Market is divided into includes mass spectrometry-based assays, PCR-based assays, ELISA-based assays, and others.

The Host Cell Protein Testing Market segmentation is based on end user that include contract research organizations, biopharmaceutical companies, and others.

Regional Insights

The North America host cell protein testing market is likely to lead the host cell protein market in future. This is because of the rising number of clinical preliminaries, rising interest for creative medication for constant sicknesses, and expanding research for quality and cell treatment items in the North American region.

Europe host cell protein testing market represents the second-biggest piece of the pie because of a rising number of clinical preliminaries in nations like Germany, and France, profoundly embraced mechanically progressed items in biopharmaceutical businesses, and agreement research associations. further, Germany host cell protein testing market was credited to hold the biggest piece of the pie, and the France host cell protein testing market is supposed to quickest developing business sector in the European region.

Major Players

The major players in the Host Cell Protein Testing Market include Enzo Life Sciences, Inc (US), Bio-Rad Laboratories, Inc (US), Biogenes GmbH (Germany), Cisbio Bioassays (France), Abcam plc (UK), Thermo Fisher Scientific Inc (US), Cytiva (US), Cygnus Technologies, LLC (US), Rockland Immunochemicals, Inc (US), and Agilent Technologies, Inc (US).

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 OVERVIEW
3.2 DATA FLOW
- 3.2.1 Data Mining Process
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
- 3.4.1 Secondary Research Data Flow:
3.5 PRIMARY RESEARCH:
- 3.5.1 Primary Research DATA FLOW:
- 3.5.2 Primary Research: Number Of Interviews Conducted
- 3.5.3 Primary Research: Regional Coverage
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
- 3.6.1 Revenue Analysis Approach
3.7 DATA FORECASTING
- 3.7.1 Data Forecasting Technique
3.8 DATA MODELING
- 3.8.1 Microeconomic Factor Analysis:
- 3.8.2 Data Modeling:
3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

4.1 OVERVIEW
4.2 DRIVERS
- 4.2.1 DEVELOPMENTS IN THE BIOPHARMACEUTICAL INDUSTRY
- 4.2.2 Growing R&D Activities
4.3 RESTRAINTS
- 4.3.1 Issues Related To The Efficiency And Accuracy Of The Test Kits
4.4 OPPORTUNITY
- 4.4.1 Growing Technological Advancements

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS
- 5.1.1 R&D And Designing
- 5.1.2 Manufacturing
- 5.1.3 Distribution & Sales
- 5.1.4 Post-Sales Review
5.2 PORTER'S FIVE FORCES MODEL
- 5.2.1 Bargaining Power Of Buyers
- 5.2.2 Bargaining Power Of Suppliers
- 5.2.3 Threat Of NEW ENTRANTS
- 5.2.4 THREAT OF SUBSTITUTES
- 5.2.5 Intensity Of Rivalry
5.3 IMPACT OF COVID-19
- 5.3.1 Impact On Supply Chain
- 5.3.2 Impact On Production
- 5.3.3 Impact On Demand-Supply Gap Analysis
5.4 TOTAL NUMBER OF SAMPLES RUN BY TYPE OF TECHNOLOGY (2022)
5.5 ANALYSIS OF REGULATORY LANDSCAPE BY REGION/COUNTRY
- 5.5.1 US
- 5.5.2 EMEA

6 GLOBAL HOST CELL PROTEIN TESTING MARKET, BY TYPE

6.1 OVERVIEW
- 6.1.1 PCR-Based Assays
- 6.1.2 ELISA-Based Assays
- 6.1.3 Mass Spectrometry-Based Assays
  - 6.1.3.1 Liquid Chromatography-Mass Spectrometry (LC-MS)
  - 6.1.3.2 Tandem Mass Spectrometry (MS/MS)
  - 6.1.3.3 Others
- 6.1.4 Others

7 GLOBAL HOST CELL PROTEIN TESTING MARKET, BY END USER

7.1 OVERVIEW
- 7.1.1 Contract Research Organizations
- 7.1.2 Biopharmaceutical Companies
- 7.1.3 Others

8 GLOBAL HOST CELL PROTEIN TESTING MARKET, BY REGION

8.1 OVERVIEW
8.2 NORTH AMERICA
- 8.2.1 US
- 8.2.2 CANADA
8.3 EUROPE
- 8.3.1 Germany
- 8.3.2 France
- 8.3.3 UK
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest Of Europe
8.4 ASIA-PACIFIC
- 8.4.1 CHINA
- 8.4.2 JAPAN
- 8.4.3 INDIA
- 8.4.4 AUSTRALIA
- 8.4.5 SOUTH KOREA
- 8.4.6 REST OF ASIA-PACIFIC
8.5 REST OF THE WORLD
- 8.5.1 MIDDLE EAST
- 8.5.2 AFRICA
- 8.5.3 LATIN AMERICA

9 COMPETITIVE LANDSCAPE

9.1 OVERVIEW
9.2 MARKET SHARE ANALYSIS, 2022
9.3 COMPETITOR DASHBOARD
9.4 PUBLIC PLAYERS STOCK SUMMARY
9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
9.6 KEY DEVELOPMENTS & GREST OF THE WORLDTH STRATEGIES
- 9.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
- 9.6.2 MERGER AND ACQUISITION
- 9.6.3 PARTNERSHIP/INVESTMENT/EXPANSION

10 COMPANY PROFILES

10.1 ENZO LIFE SCIENCES, INC
- 10.1.1 COMPANY OVERVIEW
- 10.1.2 FINANCIAL OVERVIEW
- 10.1.3 PRODUCTS OFFERED
- 10.1.4 KEY DEVELOPMENTS
- 10.1.5 SWOT ANALYSIS
- 10.1.6 KEY STRATEGIES
10.2 BIO-RAD LABORATORIES, INC
- 10.2.1 COMPANY OVERVIEW
- 10.2.2 FINANCIAL OVERVIEW
- 10.2.3 PRODUCTS OFFERED
- 10.2.4 KEY DEVELOPMENTS
- 10.2.5 SWOT ANALYSIS
- 10.2.6 KEY STRATEGIES
10.3 BIOGENES GMBH
- 10.3.1 COMPANY OVERVIEW
- 10.3.2 FINANCIAL OVERVIEW
- 10.3.3 PRODUCTS OFFERED
- 10.3.4 KEY DEVELOPMENTS
- 10.3.5 KEY STRATEGIES
10.4 CISBIO BIOASSAYS
- 10.4.1 COMPANY OVERVIEW
- 10.4.2 FINANCIAL OVERVIEW
- 10.4.3 PRODUCTS OFFERED
- 10.4.4 KEY DEVELOPMENTS
- 10.4.5 KEY STRATEGIES
10.5 ABCAM PLC
- 10.5.1 COMPANY OVERVIEW
- 10.5.2 FINANCIAL OVERVIEW
- 10.5.3 PRODUCTS OFFERED
- 10.5.4 KEY DEVELOPMENTS
- 10.5.5 KEY STRATEGIES
10.6 THERMO FISHER SCIENTIFIC INC
- 10.6.1 COMPANY OVERVIEW
- 10.6.2 FINANCIAL OVERVIEW
- 10.6.3 DISEASE TYPES OFFERed
- 10.6.4 KEY DEVELOPMENTS
- 10.6.5 SWOT ANALYSIS
- 10.6.6 Key Strategy
10.7 CYTIVA
- 10.7.1 COMPANY OVERVIEW
- 10.7.2 FINANCIAL OVERVIEW
- 10.7.3 Products OFFERed
- 10.7.4 KEY DEVELOPMENTS
- 10.7.5 SWOT Analysis
- 10.7.6 KEY STRATEGIES
10.8 CYGNUS TECHNOLOGIES, LLC
- 10.8.1 COMPANY OVERVIEW
- 10.8.2 FINANCIAL OVERVIEW
- 10.8.3 Products OFFERed
- 10.8.4 KEY DEVELOPMENTS
- 10.8.5 Key Strategy
10.9 ROCKLAND IMMUNOCHEMICALS, INC
- 10.9.1 COMPANY OVERVIEW
- 10.9.2 FINANCIAL OVERVIEW
- 10.9.3 DISEASE TYPES OFFERed
- 10.9.4 KEY DEVELOPMENTS
- 10.9.5 KEY STRATEGIES
10.10 AGILENT TECHNOLOGIES, INC
- 10.10.1 COMPANY OVERVIEW
- 10.10.2 FINANCIAL OVERVIEW
- 10.10.3 DISEASE TYPES OFFERed
- 10.10.4 KEY DEVELOPMENTS
- 10.10.5 SWOT ANALYSIS
- 10.10.6 KEY STRATEGIES

한글목차

목차

제1장 주요 요약

제2장 시장 개요

제3장 조사 방법

제4장 시장 역학

제5장 시장 요인 분석

제6장 세계의 숙주 세포 단백질 검사 시장 : 유형별

제7장 세계의 숙주 세포 단백질 검사 시장 : 최종 사용자별

제8장 세계의 숙주 세포 단백질 검사 시장 : 지역별

제9장 경쟁 구도

제10장 기업 프로파일

제11장 데이터 인용